Área salud
Clinical efficacy and safety profile of biological therapies versus standard interventions in MS and NMOSD relapses: A systematic review
Background Multiple sclerosis (MS) and neuromyelitis optica spectrum disorders (NMOSDs) are characterized by relapses that contribute to accumulating disability. Over the past decade, monoclonal antibodies have increasingly replaced standard interventions (placebo or conventional immunosuppressants) due […]